Company Profile

Kadmus Pharmaceuticals Inc (AKA: Kadmus Inc)
Profile last edited on: 8/22/07      CAGE:       UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

101 Theory Suite 100
Irvine, CA 92612
   (949) 725-3700
Location: Single
Congr. District: 45
County: Orange

Public Profile

Kadmus Pharmaceuticals Inc commercially exploits endocannabinoid pathways to develop innovative therapeutics. Endocannabinoids are naturally occurring signaling molecules whose functions include regulating pain and body weight. Through licensing activity, development partnerships and internal discovery programs, Kadmus Pharmaceuticals is building a portfolio of compounds with activity against a range of disorders of the central nervous system and metabolic disorders, including neuropathic pain and obesity

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2005 1 NIH $100,000
Project Title: Oleylethanolamide derivatives as anti-obesity agents
2001 1 NIH $127,231
Project Title: Identifying Ligands For A Novel Gabaa Receptor Subtype

Key People / Management

  Patrick Walsh -- President

  Kelvin W Gee

Company News

There are no news available.